INBX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.80%

Insider Buying (Last 12 Months): $39,999,990.00

Insider Selling (Last 12 Months): $9,215,542.05

Inhibrx Insider Trading History Chart

Inhibrx Share Price & Price History

^$24.89

▼ -0.37 (-1.46%)

As of 02/7/2023 05:19 PM ET

Days: 30 | 90 | 365

The #1 Energy Stock to Buy

From Wall Street Watch Dogs | Ad

The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…

Get the Name & Ticker Here

Inhibrx Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/1/2023	Brendan P. Eckelman	Insider	Sell	28,750	$24.73	$710,987.50	2,086,803
1/23/2023	Jon Faiz Kayyem	Director	Sell	9,500	$25.26	$239,970.00	3,224,301
1/23/2023	Mark Lappe	CEO	Sell	21,665	$25.36	$549,424.40	2,490,587
1/3/2023	Brendan P. Eckelman	Insider	Sell	32,895	$23.77	$781,914.15	2,122,658
12/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$27.02	$256,690.00	3,233,801
12/19/2022	Mark Lappe	CEO	Sell	26,000	$25.56	$664,560.00	2,512,252
12/6/2022	Brendan P. Eckelman	Insider	Sell	40,000	$27.22	$1,088,800.00	2,155,553
11/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$29.89	$283,955.00	3,243,301
11/1/2022	Brendan P. Eckelman	Insider	Sell	40,000	$33.51	$1,340,400.00	2,195,553
10/21/2022	Jon Faiz Kayyem	Director	Sell	9,500	$30.13	$286,235.00	3,252,801
10/17/2022	Mark Lappe	CEO	Sell	26,000	$29.59	$769,340.00	2,564,252
10/7/2022	Global Investors Lp Viking	Major Shareholder	Buy	1,333,333	$30.00	$39,999,990.00	2,427,307
10/4/2022	Brendan P. Eckelman	Insider	Sell	40,000	$27.82	$1,112,800.00	2,235,553
8/2/2022	Brendan P. Eckelman	Insider	Sell	24,500	$17.70	$433,650.00	2,491,053
7/7/2022	Brendan P. Eckelman	Insider	Sell	40,000	$17.17	$686,800.00	2,515,553
4/5/2022	Brendan P. Eckelman	Insider	Sell	400	$25.04	$10,016.00
3/24/2021	Brendan P. Eckelman	Insider	Sell	17,000	$19.02	$323,340.00
2/16/2021	Brendan P. Eckelman	Insider	Sell	17,000	$25.90	$440,300.00	234,709
8/26/2020	Global Investors Lp Viking	Major Shareholder	Buy	180,219	$18.92	$3,409,743.48
8/24/2020	Global Investors Lp Viking	Major Shareholder	Buy	46,161	$19.43	$896,908.23

Solar Industry at Start of Long Bull Run?

From Investing Trends | Ad

The U.S. solar industry generated nearly $33 billion of private investment in the American economy in 2021 -- and analysts say it looks like the start of a long solar bull market. Leading the way is the just-signed Inflation Reduction Act of 2022. With its generous investment tax credits, the Act is expected to triple U.S. solar energy production over the next 5 years.

See Who Could Benefit From the Flow of Money

SEC Filings (Institutional Ownership Changes) for Inhibrx (NASDAQ:INBX)

72.79% of Inhibrx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Inhibrx Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/6/2023	Los Angeles Capital Management LLC	41,399	$1.02M	0.0%	-32.2%	0.095%
2/2/2023	SG Americas Securities LLC	4,339	$0.11M	0.0%	-29.6%	0.010%
12/8/2022	Bank of New York Mellon Corp	96,949	$1.74M	0.0%	+17.2%	0.223%
11/17/2022	M&T Bank Corp	27,068	$0.49M	0.0%	-18.4%	0.062%
11/16/2022	BNP Paribas Arbitrage SNC	49,318	$0.89M	0.0%	N/A	0.113%
11/15/2022	Alliancebernstein L.P.	35,200	$0.63M	0.0%	-82.1%	0.081%
11/15/2022	State Street Corp	2,040,054	$36.62M	0.0%	+282.7%	4.684%
11/15/2022	Two Sigma Advisers LP	149,800	$2.69M	0.0%	+238.9%	0.344%
11/15/2022	Two Sigma Investments LP	163,489	$2.94M	0.0%	+31.6%	0.375%
11/15/2022	Tybourne Capital Management HK Ltd.	645,815	$11.59M	1.1%	-18.7%	1.483%
11/15/2022	Vanguard Group Inc.	1,467,918	$26.35M	0.0%	+8.2%	3.371%
11/15/2022	Perceptive Advisors LLC	2,887,860	$51.84M	1.5%	+50.8%	6.631%
11/15/2022	Platinum Investment Management Ltd.	146,210	$2.62M	0.1%	-8.7%	0.336%
11/15/2022	Lido Advisors LLC	11,549	$0.21M	0.0%	-9.0%	0.027%
11/15/2022	Ensign Peak Advisors Inc	6,260	$0.11M	0.0%	+114.4%	0.014%
11/15/2022	Bank of New York Mellon Corp	96,949	$1.74M	0.0%	+17.2%	0.223%
11/15/2022	Bellevue Group AG	43,500	$0.78M	0.0%	-43.2%	0.100%
11/15/2022	Bioimpact Capital LLC	1,279,995	$22.98M	5.4%	+25.1%	2.939%
11/15/2022	BlackRock Inc.	2,190,518	$39.32M	0.0%	+10.8%	5.030%
11/14/2022	Tudor Investment Corp Et Al	20,358	$0.37M	0.0%	+7.8%	0.047%
11/14/2022	Point72 Asset Management L.P.	457,100	$8.21M	0.0%	-34.6%	1.050%
11/14/2022	Cubist Systematic Strategies LLC	76,825	$1.38M	0.0%	+27.2%	0.176%
11/14/2022	Nuveen Asset Management LLC	114,916	$2.06M	0.0%	-0.4%	0.264%
11/14/2022	UBS Oconnor LLC	71,297	$1.28M	0.0%	-16.2%	0.164%
11/10/2022	Credit Suisse AG	19,926	$0.36M	0.0%	+66.6%	0.046%
11/10/2022	Tower Research Capital LLC TRC	5,653	$0.10M	0.0%	+24.6%	0.014%
11/10/2022	UBS Group AG	17,795	$0.32M	0.0%	N/A	0.046%
11/9/2022	Zurcher Kantonalbank Zurich Cantonalbank	3,704	$66K	0.0%	+418.0%	0.009%
11/8/2022	New York State Common Retirement Fund	20,157	$0.36M	0.0%	-7.0%	0.052%
11/7/2022	Nisa Investment Advisors LLC	2,346	$47K	0.0%	+633.1%	0.006%
11/7/2022	Jump Financial LLC	10,650	$0.19M	0.0%	-65.9%	0.027%
11/4/2022	Russell Investments Group Ltd.	340,604	$6.11M	0.0%	+34.0%	0.872%
11/3/2022	The Manufacturers Life Insurance Company	12,211	$0.22M	0.0%	-3.6%	0.031%
11/3/2022	Barclays PLC	87,078	$1.52M	0.0%	+2,711.7%	0.223%
11/2/2022	Los Angeles Capital Management LLC	61,030	$1.10M	0.0%	N/A	0.156%
11/2/2022	Victory Capital Management Inc.	76,860	$1.38M	0.0%	-13.7%	0.197%
10/31/2022	SG Americas Securities LLC	6,159	$0.11M	0.0%	N/A	0.016%
8/30/2022	Verition Fund Management LLC	95,076	$1.08M	0.0%	N/A	0.243%
8/22/2022	Legal & General Group Plc	8,383	$95K	0.0%	+52.7%	0.021%
8/22/2022	ExodusPoint Capital Management LP	67,233	$0.76M	0.0%	N/A	0.172%
8/19/2022	Walleye Capital LLC	68,138	$0.77M	0.0%	-38.4%	0.174%
8/18/2022	Goldman Sachs Group Inc.	80,447	$0.91M	0.0%	-44.3%	0.206%
8/15/2022	State Street Corp	533,068	$6.05M	0.0%	-66.6%	1.365%
8/15/2022	Point72 Hong Kong Ltd	2,879	$33K	0.0%	+154.6%	0.007%
8/15/2022	Cubist Systematic Strategies LLC	60,396	$0.69M	0.0%	+316.5%	0.155%
8/15/2022	Point72 Asset Management L.P.	699,100	$7.94M	0.0%	N/A	1.790%
8/15/2022	Opaleye Management Inc.	590,000	$6.70M	3.0%	N/A	1.511%
8/15/2022	Millennium Management LLC	947,031	$10.75M	0.0%	N/A	2.425%
8/15/2022	Sio Capital Management LLC	365,210	$4.15M	1.6%	+193.9%	0.935%
8/15/2022	UBS Asset Management Americas Inc.	10,080	$0.11M	0.0%	N/A	0.026%
8/13/2022	Quantbot Technologies LP	5,915	$67K	0.0%	+90.8%	0.015%
8/12/2022	Northern Trust Corp	260,179	$2.95M	0.0%	+2.4%	0.666%
8/12/2022	Virtus ETF Advisers LLC	12,172	$0.14M	0.1%	+206.8%	0.031%
8/12/2022	Ikarian Capital LLC	49,372	$0.56M	0.1%	-79.7%	0.126%
8/12/2022	Credit Suisse AG	11,960	$0.14M	0.0%	N/A	0.031%
8/12/2022	FMR LLC	1,444,642	$16.40M	0.0%	-0.1%	3.699%
8/12/2022	Rhumbline Advisers	32,844	$0.37M	0.0%	+15.6%	0.084%
8/11/2022	Bioimpact Capital LLC	1,023,325	$11.62M	3.2%	N/A	2.621%
8/11/2022	Trexquant Investment LP	16,732	$0.19M	0.0%	N/A	0.043%
8/11/2022	Platinum Investment Management Ltd.	160,099	$1.82M	0.1%	+84.2%	0.410%
8/11/2022	JPMorgan Chase & Co.	25,335	$0.29M	0.0%	+7.3%	0.065%
8/9/2022	Swiss National Bank	53,600	$0.61M	0.0%	+138.2%	0.137%
8/8/2022	Walleye Capital LLC	68,138	$0.77M	0.0%	-38.4%	0.175%
8/5/2022	State Board of Administration of Florida Retirement System	10,688	$0.12M	0.0%	N/A	0.027%
8/5/2022	M&T Bank Corp	33,172	$0.38M	0.0%	+182.5%	0.085%
8/5/2022	Loomis Sayles & Co. L P	1,036,295	$11.76M	0.0%	-0.4%	2.654%
8/3/2022	Candriam S.C.A.	352,069	$4M	0.0%	+31.6%	0.902%
8/1/2022	Victory Capital Management Inc.	89,060	$1.01M	0.0%	-10.9%	0.228%
7/29/2022	Russell Investments Group Ltd.	254,112	$2.88M	0.0%	+54.2%	0.651%
6/7/2022	Bank of America Corp DE	58,368	$1.30M	0.0%	+25.8%	0.150%
5/27/2022	Walleye Capital LLC	110,532	$2.46M	0.0%	+99.0%	0.283%
5/17/2022	Walleye Capital LLC	110,532	$2.46M	0.1%	+99.0%	0.283%
5/17/2022	Quantbot Technologies LP	3,100	$69K	0.0%	+158.3%	0.008%
5/17/2022	Royal Bank of Canada	2,100	$47K	0.0%	-65.9%	0.005%
5/16/2022	California State Teachers Retirement System	20,480	$0.46M	0.0%	-11.6%	0.052%
5/16/2022	Goldman Sachs Group Inc.	144,479	$3.22M	0.0%	+18.4%	0.370%
5/16/2022	Connacht Asset Management LP	12,361	$0.28M	0.1%	+74.2%	0.032%
5/16/2022	Wellington Management Group LLP	118,506	$2.64M	0.0%	-92.1%	0.304%
5/16/2022	State Street Corp	1,596,095	$35.56M	0.0%	+75.5%	4.089%
5/16/2022	Vident Investment Advisory LLC	26,940	$0.60M	0.0%	+20.0%	0.069%
5/16/2022	Graham Capital Management L.P.	9,135	$0.20M	0.0%	N/A	0.023%
5/16/2022	Invesco Ltd.	11,358	$0.25M	0.0%	-78.2%	0.029%
5/16/2022	UBS Group AG	32,343	$0.72M	0.0%	-12.5%	0.083%
5/13/2022	Bellevue Group AG	49,700	$1.11M	0.0%	-1.6%	0.127%
5/13/2022	Northern Trust Corp	254,178	$5.66M	0.0%	-2.7%	0.651%
5/13/2022	Charles Schwab Investment Management Inc.	164,530	$3.67M	0.0%	+2.2%	0.421%
5/13/2022	American International Group Inc.	13,859	$0.31M	0.0%	-6.6%	0.035%
5/13/2022	Loomis Sayles & Co. L P	1,040,415	$23.18M	0.0%	N/A	2.665%
5/13/2022	Candriam Luxembourg S.C.A.	267,437	$5.96M	0.0%	-28.7%	0.685%
5/13/2022	Vanguard Group Inc.	1,218,113	$27.14M	0.0%	+0.9%	3.120%
5/12/2022	BlackRock Inc.	1,902,147	$42.38M	0.0%	+0.4%	4.874%
5/12/2022	Rhumbline Advisers	28,409	$0.63M	0.0%	+13.1%	0.073%
5/12/2022	Metropolitan Life Insurance Co NY	2,082	$46K	0.0%	-73.3%	0.005%
5/12/2022	MetLife Investment Management LLC	17,227	$0.38M	0.0%	+49.5%	0.044%
5/12/2022	Citigroup Inc.	16,926	$0.38M	0.0%	-54.4%	0.043%
5/12/2022	HighTower Advisors LLC	10,000	$0.22M	0.0%	N/A	0.026%
5/11/2022	Bank of New York Mellon Corp	86,174	$1.92M	0.0%	+1.2%	0.221%
5/11/2022	JPMorgan Chase & Co.	23,614	$0.53M	0.0%	-61.5%	0.061%
5/10/2022	ProShare Advisors LLC	9,273	$0.21M	0.0%	-18.9%	0.024%
5/9/2022	Swiss National Bank	22,500	$0.50M	0.0%	+5.6%	0.058%

Data available starting January 2016

Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.

Today's Range

Now: $24.89

$23.87

$25.32

50 Day Range

MA: $25.86

$22.13

$32.50

52 Week Range

Now: $24.89

$7.67

$34.72

Volume

406,124 shs

Average Volume

402,137 shs

Market Capitalization

$1.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.97

Who are the company insiders with the largest holdings of Inhibrx?: Inhibrx's top insider shareholders include:
Jon Faiz Kayyem (Director)
Mark Lappe (CEO)
Brendan P Eckelman (Insider)
Global Investors Lp Viking (Major Shareholder)
Learn More about top insider investors at Inhibrx.
Who are the major institutional investors of Inhibrx?: Inhibrx's top institutional shareholders include:
Los Angeles Capital Management LLC — 0.10%
SG Americas Securities LLC — 0.01%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Inhibrx stock.
Which major investors are selling Inhibrx stock?: Within the last quarter, INBX stock was sold by these institutional investors:
Los Angeles Capital Management LLC
SG Americas Securities LLC
In the last year, company insiders that have sold Inhibrx company stock include:
Jon Faiz Kayyem (Director)
Mark Lappe (CEO)
Brendan P Eckelman (Insider)
Learn More investors selling Inhibrx stock.